20 July, 2017
Franklin Resources Inc. boosted its position in Gilead Sciences by 2.2% in the fourth quarter. The Leavell Investment Management Inc holds 20,138 shares with $1.44 million value, down from 26,352 last quarter. After $2.20 actual EPS reported by Gilead Sciences, Inc. for the previous quarter, Wall Street now forecasts -5.00% negative EPS growth. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since July 20, 2016 and is downtrending. The stock was sold at an average price of $67.25, for a total value of $668,666.75. The company has market cap of $660.61 million. Ebay Inc now has $39.86 billion valuation.
The stock increased 0.60% or $0.06 during the last trading session, reaching $10.11. About 125,970 shares traded or 115.74% up from the average. It has outperformed by 27.75% the S&P500.
Since March 3, 2017, it had 0 insider buys, and 2 selling transactions for $266,185 activity. Its share price has risen 17.30% in three months and is up 3.56% for the last five trades. $25,416 worth of Time Warner Inc (NYSE:TWX) was bought by Averill Howard M. The average analysts gave this company a mean recommendation of 1.70. (NYSE:TWX), 16 have Buy rating, 0 Sell and 18 Hold. Therefore 79% are positive. Shares price isolated negatively from its 50 days moving average with -0.58% and remote positively from 200 days moving average with 6.32%. As per Friday, February 12, the company rating was maintained by Maxim Group. The company was maintained on Monday, June 12 by Jefferies. The rating was maintained by Scotia Capital on Friday, December 9 with "Outperform". The firm has "Hold" rating given on Thursday, April 20 by Pivotal Research. On November 2, 2016 the stock rating was rated "Outperform" in a report from BMO Capital which is up from the previous "Market Perform" rating. Morgan Stanley has "Equal-Weight" rating and $127 target.
Investors sentiment increased to 1.33 in Q4 2016. Its up 0.07, from 1.02 in 2016Q3. 88 funds opened positions while 236 raised stakes.
Associated Banc-Corp increased Honeywell Intl Inc (NYSE:HON) stake by 34,162 shares to 36,080 valued at $4.18 million in 2016Q4. (NASDAQ:GILD). Horizon Kinetics Limited Liability Company owns 13,000 shares for 0.03% of their portfolio. Btr Mgmt has 110,187 shares for 1.96% of their portfolio. Great West Life Assurance Com Can invested in 3,693 shares. Quantitative Investment Mgmt Limited Liability Company accumulated 33,500 shares. Shell Asset Mngmt holds 0.45% or 281,979 shares. Loomis Sayles And Communication Lp owns 1,290 shares. Daiwa Sb Invs Limited, a Japan-based fund reported 360 shares. As of quarter end Tb Alternative Assets Ltd. had bought 1,500 shares growing its stake by 3.9%. Eqis owns 20,792 shares or 0.08% of their U.S. portfolio. Bessemer Grp reported 4,590 shares.
GILD has been the subject of a number of analyst reports. The biopharmaceutical company reported $2.20 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.18 by $0.02. PRSC's profit would be $2.93M giving it 56.27 P/E if the $0.22 EPS is correct. After having $-0.13 EPS previously, PHX Energy Services Corp's analysts see 15.38% EPS growth. Therefore 60% are positive.
Calamos Wealth Management Llc decreased Gilead Sciences Inc (GILD) stake by 13.05% reported in 2016Q4 SEC filing. The company now has an average rating of "Buy" and a consensus target price of $80.24. Jefferies Group LLC reaffirmed a "buy" rating on shares of Gilead Sciences in a report on Wednesday, March 22nd. The rating was maintained by Oppenheimer on Wednesday, July 29 with "Outperform". Gilead Sciences makes up 0.9% of American Assets Investment Management LLC's portfolio, making the stock its 23rd largest position. (NASDAQ:GILD) on Wednesday, July 29 with "Buy" rating. Kennedy Cap Management invested 0.04% in The Providence Service Corporation (NASDAQ:PRSC). (NASDAQ:GILD) on Wednesday, September 9 with "Hold" rating. A rating of 4 or 5 would represent a Sell recommendation. Gabelli initiated Gilead Sciences, Inc. The rating was maintained by William Blair with "Buy" on Wednesday, June 14. The company was downgraded on Tuesday, July 26 by Needham. Gilead Sciences presently has a consensus rating of "Buy" and a consensus price target of $80.58. As per Thursday, February 25, the company rating was initiated by Citigroup.
Since February 1, 2017, it had 0 buys, and 10 sales for $28.29 million activity. In the last quarter, insiders sold 88,276 shares of company stock valued at $6,230,610. WILSON GAYLE E sold $1.41M worth of stock. Also, insider John C. Martin sold 73,333 shares of the firm's stock in a transaction that occurred on Monday, July 3rd.
Investors sentiment decreased to 0.7 in 2016 Q4. Its up 0.22, from 0.75 in 2016Q3. It dived, as 106 investors sold GILD shares while 656 reduced holdings. 48 funds opened positions while 57 raised stakes. 950.84 million shares or 0.69% more from 944.29 million shares in 2016Q3 were reported. Da Davidson & holds 0% or 580 shares. Murphy Capital reported 9,995 shares. About shares traded. Trillium Therapeutics Inc. Segall Bryant Hamill Llc invested 0.42% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Schmidt P J Investment Mngmt stated it has 0.27% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Appleton Ma reported 0.82% in Gilead Sciences, Inc. (NASDAQ:GILD). Carroll Fincl Assocs invested in 0.05% or 5,105 shares. Boulegeris has invested 2.51% in Gilead Sciences, Inc. "(NASDAQ:GILD)" was first published by Markets Daily and is the property of of Markets Daily. (NASDAQ:GILD). Us Bancorporation De holds 924,404 shares. 376,285 were accumulated by Envestnet Asset Mgmt. Florida-based Ifc Holding Fl has invested 0.09% in Gilead Sciences, Inc. (NASDAQ:GILD). Great Lakes Limited Liability Company has invested 0.12% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD) on Thursday, September 22 with "Buy" rating. Moreover, Kennedy Capital Management Inc. has 0.06% invested in the company for 324,749 shares.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.